196 related articles for article (PubMed ID: 16505777)
1. [Vestibular neurotomy versus chemical labyrinthectomy for disabling Menière disease].
Morel N; Dumas G; Nguyen DQ; Mohr E; Hitter A; Schmerber S
Ann Otolaryngol Chir Cervicofac; 2005 Dec; 122(6):271-80. PubMed ID: 16505777
[TBL] [Abstract][Full Text] [Related]
2. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
Schmerber S; Dumas G; Morel N; Chahine K; Karkas A
Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
[TBL] [Abstract][Full Text] [Related]
3. Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Ménière's disease.
Schlegel M; Vibert D; Ott SR; Häusler R; Caversaccio MD
Otol Neurotol; 2012 Oct; 33(8):1380-5. PubMed ID: 22931868
[TBL] [Abstract][Full Text] [Related]
4. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
Colletti V; Carner M; Colletti L
Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
[TBL] [Abstract][Full Text] [Related]
5. Comparison of VEMPs, VHIT and caloric test outcomes after vestibular neurectomy in Menière's disease.
Canale A; Caranzano F; Lanotte M; Ducati A; Calamo F; Albera A; Lacilla M; Boldreghini M; Lucisano S; Albera R
Auris Nasus Larynx; 2018 Dec; 45(6):1159-1165. PubMed ID: 29747962
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of transtympanic gentamicin for Ménière's syndrome.
Harner SG; Driscoll CL; Facer GW; Beatty CW; McDonald TJ
Otol Neurotol; 2001 Mar; 22(2):210-4. PubMed ID: 11300271
[TBL] [Abstract][Full Text] [Related]
7. [Chemical labyrinthectomy: results and applications].
Mondain M; Mouchet F; Marlier F; Makeieff M; Biboulet R; Uziel A
Ann Otolaryngol Chir Cervicofac; 1998 Oct; 115(4):234-42. PubMed ID: 9827191
[TBL] [Abstract][Full Text] [Related]
8. Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease.
Junet P; Karkas A; Dumas G; Quesada JL; Schmerber S
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3011-8. PubMed ID: 26780342
[TBL] [Abstract][Full Text] [Related]
9. An update on the surgical treatment of Ménière's diseases.
Ghossaini SN; Wazen JJ
J Am Acad Audiol; 2006 Jan; 17(1):38-44. PubMed ID: 16640059
[TBL] [Abstract][Full Text] [Related]
10. Gentamicin perfusion vestibular response and hearing loss.
Light JP; Silverstein H; Jackson LE
Otol Neurotol; 2003 Mar; 24(2):294-8. PubMed ID: 12621347
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
12. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
14. Transmastoid labyrinthectomy versus translabyrinthine vestibular nerve section: does cutting the vestibular nerve make a difference in outcome?
De La Cruz A; Borne Teufert K; Berliner KI
Otol Neurotol; 2007 Sep; 28(6):801-8. PubMed ID: 17948358
[TBL] [Abstract][Full Text] [Related]
15. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin in monolateral Meniere's disease: our experience.
Bertino G; Durso D; Manfrin M; Casati L; Mira E
Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):271-5. PubMed ID: 16021460
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
Li CS; Lai JT
Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic gentamicin treatment after endolymphatic sac surgery.
Gouveris H; Lange G; Mann WJ
Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
20. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
